MicroRNAs in cardiovascular disease

Cardiovascular disease (CVD) remains the predominant cause of human morbidity and mortality in developed countries. Currently, microRNAs have been investigated in many diseases as well-promising biomarkers for diagnosis, prognosis, and disease monitoring. Plenty studies have been designed so as to e...

Full description

Saved in:
Bibliographic Details
Published in:Hellenic journal of cardiology 2020-05, Vol.61 (3), p.165-173
Main Authors: Siasos, Gerasimos, Bletsa, Evanthia, Stampouloglou, Panagiota K., Oikonomou, Evangelos, Tsigkou, Vasiliki, Paschou, Stavroula A., Vlasis, Konstantinos, Marinos, Georgios, Vavuranakis, Manolis, Stefanadis, Christodoulos, Tousoulis, Dimitris
Format: Article
Language:English
Subjects:
Atherosclerosis
Biomarkers
Cardiovascular disease
MicroRNAs
Molecular cardiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiovascular disease (CVD) remains the predominant cause of human morbidity and mortality in developed countries. Currently, microRNAs have been investigated in many diseases as well-promising biomarkers for diagnosis, prognosis, and disease monitoring. Plenty studies have been designed so as to elucidate the properties of microRNAs in the classification and risk stratification of patients with CVD and also to evaluate their potentials in individualized management and guide treatment decisions. Therefore, in this review article, we aimed to present the most recent data concerning the role of microRNAs as potential novel biomarkers for cardiovascular disease. [Display omitted]
ISSN:1109-9666
2241-5955
DOI:10.1016/j.hjc.2020.03.003